Applications of 4-(4-Oxo-2-Thioxo-Thiazolidin-3-Yl)-Butyric Acid in Industrial Manufacturing

Our advanced production of 4-(4-Oxo-2-Thioxo-Thiazolidin-3-Yl)-Butyric Acid supplies global manufacturers across selected specialty chemical sectors, where precise formulation and process consistency drive quality outcomes. The applications below reflect real industrial downstream uses—with regulatory benchmarks, typical incorporation rates, workflow positioning, and manufactured end products specific to each field.

1. Active Pharmaceutical Ingredient (API) Synthesis – Thiazolidine-Based Drug Intermediates

This molecule finds dedicated use in pharmaceutical manufacturing as a building block for certain thiazolidine core APIs and their derivatives. It integrates at early-stage reaction set-ups for antihyperglycemic, anti-inflammatory, and enzyme-modulating drug intermediates. Specification and purity directly impact API yields, influencing both reaction efficiency and final pharmacopoeial compliance.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) monographs for intermediates
• United States Pharmacopeia (USP) for related substances and residual solvents
• US FDA 21 CFR Parts 210 & 211 for GMP standards in drug manufacturing

Typical usage ratio

• 5–15% by mass in multi-step synthesis; actual charge varies by downstream API design and desired yield; chemists adjust ratio per stoichiometric formula and reaction scale

Downstream process integration

• Charged in initial condensation or ring formation stage; follows controlled pH adjustment and critical temperature control to enable subsequent functional group additions

Final product types

• Antidiabetic drug intermediates (e.g., glitazone class precursors)
• Anti-inflammatory compounds containing thiazolidine scaffolds
• Custom intermediates for contract drug synthesis (CDMO sector)

2. Specialty Agrochemical Synthesis – Pesticide and Fungicide Intermediates

Producers of advanced agrochemical actives rely on this compound to introduce thiazolidine moieties into pesticide and fungicide molecules. Its function as a masked sulfur donor and heterocycle precursor brings needed bioactivity for field formulations. Consistent product quality during synthesis is essential for batch-to-batch reproducibility and regulatory inspection.

Industry compliance standards

• Food and Agriculture Organization (FAO) Specifications for plant protection products
• OECD Guidelines on the Testing of Chemicals (for impurity profiling)
• ISO 9001:2015 Quality Management Systems for manufacturing operations
• EU Regulation (EC) No 1107/2009 for pesticide authorisation

Typical usage ratio

• 3–8% relative to final pesticide molecule mass; adjusted according to target active ingredient synthesis protocol and regulatory required impurity limits

Downstream process integration

• Added after initial formation of the base substrate; participates in nucleophilic substitution or cyclization reactions during the core structure-building phase

Final product types

• Thiazolidinone-derived fungicides for seed treatments
• Sulfur-containing pesticide intermediates for crop protection
• Custom intermediates for R&D-scale biological trials

3. Fine Chemical Manufacturing – Heterocyclic Compound Synthesis

Within fine chemical operations, this raw material supports the targeted assembly of heterocyclic frameworks utilized in advanced materials, chemical sensors, and dyestuff intermediates. Its reactive sites enable streamlined synthesis of functionalized thiazolidinones, supporting strict process control and reproducibility in multi-kilo production.

Industry compliance standards

• REACH Registration, Evaluation, Authorisation and Restriction of Chemicals (EU)
• ISO 14001:2015 for Environmental Management in chemical manufacturing
• GHS (Globally Harmonized System) for hazard labelling and transport
• Responsible Care® Management System (global chemical sector)

Typical usage ratio

• 2–7% by mass in heterocycle-forming reactions; flexibly adapted to desired product substitution pattern and reactivity balance with catalysis systems

Downstream process integration

• Introduced at the functionalization or cyclization stage post-initial aromatic or aliphatic scaffold assembly; monitored for purity and reaction endpoint by in-process analytical QC

Final product types

• Functional dyes and pigments incorporating thiazolidine rings
• Sensing molecule intermediates for analytical devices
• Customized heterocyclic intermediates for specialty chemical formulations

4. Research Chemical Supply – Thiazolidine Scaffold Synthesis for Discovery Chemistry

Research laboratories and discovery chemistry units order this compound as a scaffold generator in custom molecule development. Its defined reactivity and functional group compatibility offer medicinal and agro researchers a reproducible tool for synthesizing new thiazolidine analogues. Detailed batch documentation and analytical traceability support preclinical R&D requirements.

Industry compliance standards

• ISO/IEC 17025 Lab Accreditation for test method validation
• OECD Good Laboratory Practice (GLP) for preclinical workflows
• Material Safety Data Sheet (MSDS) conformance under GHS
• ROHS and SVHC screening for laboratory chemical inventory

Typical usage ratio

• Flexible: 1–20% with molar charge calculated by research chemist per target compound design; scaling from milligram to multi-gram according to experimental run size

Downstream process integration

• Serves in early-stage library synthesis or route scouting; typically charged during core scaffold assembly, with downstream customization via substituent addition or derivatization

Final product types

• Reference compounds for bioactivity screening
• Analytical standards for forensic or academic investigations
• Lead scaffold analogues in medicinal and synthetic method development